A Randomized Controlled Trial to evaluate the Efficacy and Safety of Alternate day therapy with Atorvastatin and Fenofibrate combination in the treatment of Mixed Dyslipidemia.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Atorvastatin/fenofibrate (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 10 Mar 2013 Planned number of patients changed from 100 to 110 as reported by Clinical Trials Registry - India record.
- 28 Sep 2010 New trial record